z-logo
open-access-imgOpen Access
Use of botulinum toxin type A in rheumatic diseases
Author(s) -
О. Н. Егорова,
Б. С. Белов,
Е. Г. Сажина
Publication year - 2021
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2021-5-108-113
Subject(s) - cochrane library , medicine , botulinum toxin , medline , meta analysis , intensive care medicine , surgery , political science , law
The article presents an analysis of modern data on the antinociceptive effectiveness of botulinum toxin type A (BTA) in rheumatic diseases (RD). The prospects for the use of BTA in the treatment of pain in different RDs are discussed. We searched for publications in the Medline, Pubmed, Cochrane Library databases. Analysis of literature data has shown that BTA can become an additional method of pain management in many RDs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here